26.08.2015 • NewsElaine BurridgeMonsantoSyngenta

Monsanto Raises Bid for Syngenta

It was surely only a matter of time before leading agrochemicals company Monsanto increased its offer again for Swiss rival Syngenta. The company is reported to have raised its bid to around $46 billion, or 470 Swiss francs per share. The break-up fee, payable should the deal fail to receive regulatory approval, was also increased from $2 billion to $3 billion.

Syngenta turned down Monsanto’s previous offers in April and May, both of which valued its shares at 449 Swiss francs. Reports say Syngenta is expected to reject this third bid too as the offer remains well below what it regards as fair value.

A survey of nearly 100 current and former Syngenta shareholders by Bernstein Research earlier this month found that 92% were in favor of a negotiated deal and most of them would accept an offer 5% higher.

Both companies have declined to comment.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read